ALPHA-GALACTOSYL CERAMIDE ANALOGS AND THEIR USE AS IMMUNOTHERAPIES, ADJUVANTS, AND INTIVIRAL, ANTIBACTERIAL, AND ANTICANCER AGENTS
The present disclosure relates to synthetic alpha-galactosyl ceramide (α-GalCer) analogs, and their use as immunotherapies. In one aspect. a method of activating a cytokine response in a subject includes administering an effective amount of a compound to a subject, wherein the subject has an adaptiv...
Gespeichert in:
Hauptverfasser: | , , , , , , , |
---|---|
Format: | Patent |
Sprache: | eng ; kor |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | |
---|---|
container_issue | |
container_start_page | |
container_title | |
container_volume | |
creator | YU ALICE CHANG YA JEN LIN YI LING JAN JIA TSRONG LIN KUN HSIEN HUNG JUNG TUNG CHENG Y. S. EDMOND WONG CHI HUEY |
description | The present disclosure relates to synthetic alpha-galactosyl ceramide (α-GalCer) analogs, and their use as immunotherapies. In one aspect. a method of activating a cytokine response in a subject includes administering an effective amount of a compound to a subject, wherein the subject has an adaptive immune system that includes a population of cells, the population including at least one lymphocyte and at least one antigen-presenting cell, and wherein the compound is represented by the structure of formula 1: or a pharmaceutically acceptable salt thereof; forming a complex between the compound and the antigen-presenting cell, wherein the formation of the complex results in the activation of a receptor on the lymphocyte; and activating the lymphocyte to produce the cytokine response. |
format | Patent |
fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_KR20110107317A</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>KR20110107317A</sourcerecordid><originalsourceid>FETCH-epo_espacenet_KR20110107317A3</originalsourceid><addsrcrecordid>eNqNjcEOgjAQRLl4MOo_NPEqCZUD56WtsFoKaQuJJ0JMPRklwS_wy13UD_A0Oy8zs8voBbopIS5Ag_C1O2smlIUKpWJgQNeFI5XMlwotax1Rx7CqWlMTstCgcjsG8th2YPx8UhiNxw4t6Nl6zGlZWfxa-UECDL1hUCgqraPFdbhNYfPTVbQ9KC_KOIyPPkzjcAn38OxPdp9wnvAkS3kG6X-pN5AbPQc</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>ALPHA-GALACTOSYL CERAMIDE ANALOGS AND THEIR USE AS IMMUNOTHERAPIES, ADJUVANTS, AND INTIVIRAL, ANTIBACTERIAL, AND ANTICANCER AGENTS</title><source>esp@cenet</source><creator>YU ALICE ; CHANG YA JEN ; LIN YI LING ; JAN JIA TSRONG ; LIN KUN HSIEN ; HUNG JUNG TUNG ; CHENG Y. S. EDMOND ; WONG CHI HUEY</creator><creatorcontrib>YU ALICE ; CHANG YA JEN ; LIN YI LING ; JAN JIA TSRONG ; LIN KUN HSIEN ; HUNG JUNG TUNG ; CHENG Y. S. EDMOND ; WONG CHI HUEY</creatorcontrib><description>The present disclosure relates to synthetic alpha-galactosyl ceramide (α-GalCer) analogs, and their use as immunotherapies. In one aspect. a method of activating a cytokine response in a subject includes administering an effective amount of a compound to a subject, wherein the subject has an adaptive immune system that includes a population of cells, the population including at least one lymphocyte and at least one antigen-presenting cell, and wherein the compound is represented by the structure of formula 1: or a pharmaceutically acceptable salt thereof; forming a complex between the compound and the antigen-presenting cell, wherein the formation of the complex results in the activation of a receptor on the lymphocyte; and activating the lymphocyte to produce the cytokine response.</description><language>eng ; kor</language><subject>HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2011</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20110930&DB=EPODOC&CC=KR&NR=20110107317A$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20110930&DB=EPODOC&CC=KR&NR=20110107317A$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>YU ALICE</creatorcontrib><creatorcontrib>CHANG YA JEN</creatorcontrib><creatorcontrib>LIN YI LING</creatorcontrib><creatorcontrib>JAN JIA TSRONG</creatorcontrib><creatorcontrib>LIN KUN HSIEN</creatorcontrib><creatorcontrib>HUNG JUNG TUNG</creatorcontrib><creatorcontrib>CHENG Y. S. EDMOND</creatorcontrib><creatorcontrib>WONG CHI HUEY</creatorcontrib><title>ALPHA-GALACTOSYL CERAMIDE ANALOGS AND THEIR USE AS IMMUNOTHERAPIES, ADJUVANTS, AND INTIVIRAL, ANTIBACTERIAL, AND ANTICANCER AGENTS</title><description>The present disclosure relates to synthetic alpha-galactosyl ceramide (α-GalCer) analogs, and their use as immunotherapies. In one aspect. a method of activating a cytokine response in a subject includes administering an effective amount of a compound to a subject, wherein the subject has an adaptive immune system that includes a population of cells, the population including at least one lymphocyte and at least one antigen-presenting cell, and wherein the compound is represented by the structure of formula 1: or a pharmaceutically acceptable salt thereof; forming a complex between the compound and the antigen-presenting cell, wherein the formation of the complex results in the activation of a receptor on the lymphocyte; and activating the lymphocyte to produce the cytokine response.</description><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2011</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqNjcEOgjAQRLl4MOo_NPEqCZUD56WtsFoKaQuJJ0JMPRklwS_wy13UD_A0Oy8zs8voBbopIS5Ag_C1O2smlIUKpWJgQNeFI5XMlwotax1Rx7CqWlMTstCgcjsG8th2YPx8UhiNxw4t6Nl6zGlZWfxa-UECDL1hUCgqraPFdbhNYfPTVbQ9KC_KOIyPPkzjcAn38OxPdp9wnvAkS3kG6X-pN5AbPQc</recordid><startdate>20110930</startdate><enddate>20110930</enddate><creator>YU ALICE</creator><creator>CHANG YA JEN</creator><creator>LIN YI LING</creator><creator>JAN JIA TSRONG</creator><creator>LIN KUN HSIEN</creator><creator>HUNG JUNG TUNG</creator><creator>CHENG Y. S. EDMOND</creator><creator>WONG CHI HUEY</creator><scope>EVB</scope></search><sort><creationdate>20110930</creationdate><title>ALPHA-GALACTOSYL CERAMIDE ANALOGS AND THEIR USE AS IMMUNOTHERAPIES, ADJUVANTS, AND INTIVIRAL, ANTIBACTERIAL, AND ANTICANCER AGENTS</title><author>YU ALICE ; CHANG YA JEN ; LIN YI LING ; JAN JIA TSRONG ; LIN KUN HSIEN ; HUNG JUNG TUNG ; CHENG Y. S. EDMOND ; WONG CHI HUEY</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_KR20110107317A3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; kor</language><creationdate>2011</creationdate><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>YU ALICE</creatorcontrib><creatorcontrib>CHANG YA JEN</creatorcontrib><creatorcontrib>LIN YI LING</creatorcontrib><creatorcontrib>JAN JIA TSRONG</creatorcontrib><creatorcontrib>LIN KUN HSIEN</creatorcontrib><creatorcontrib>HUNG JUNG TUNG</creatorcontrib><creatorcontrib>CHENG Y. S. EDMOND</creatorcontrib><creatorcontrib>WONG CHI HUEY</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>YU ALICE</au><au>CHANG YA JEN</au><au>LIN YI LING</au><au>JAN JIA TSRONG</au><au>LIN KUN HSIEN</au><au>HUNG JUNG TUNG</au><au>CHENG Y. S. EDMOND</au><au>WONG CHI HUEY</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>ALPHA-GALACTOSYL CERAMIDE ANALOGS AND THEIR USE AS IMMUNOTHERAPIES, ADJUVANTS, AND INTIVIRAL, ANTIBACTERIAL, AND ANTICANCER AGENTS</title><date>2011-09-30</date><risdate>2011</risdate><abstract>The present disclosure relates to synthetic alpha-galactosyl ceramide (α-GalCer) analogs, and their use as immunotherapies. In one aspect. a method of activating a cytokine response in a subject includes administering an effective amount of a compound to a subject, wherein the subject has an adaptive immune system that includes a population of cells, the population including at least one lymphocyte and at least one antigen-presenting cell, and wherein the compound is represented by the structure of formula 1: or a pharmaceutically acceptable salt thereof; forming a complex between the compound and the antigen-presenting cell, wherein the formation of the complex results in the activation of a receptor on the lymphocyte; and activating the lymphocyte to produce the cytokine response.</abstract><oa>free_for_read</oa></addata></record> |
fulltext | fulltext_linktorsrc |
identifier | |
ispartof | |
issn | |
language | eng ; kor |
recordid | cdi_epo_espacenet_KR20110107317A |
source | esp@cenet |
subjects | HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
title | ALPHA-GALACTOSYL CERAMIDE ANALOGS AND THEIR USE AS IMMUNOTHERAPIES, ADJUVANTS, AND INTIVIRAL, ANTIBACTERIAL, AND ANTICANCER AGENTS |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-05T08%3A48%3A31IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=YU%20ALICE&rft.date=2011-09-30&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EKR20110107317A%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |